- Home
- CRVO vs ATLX Comparison
CRVO vs ATLX Comparison
Compare CRVO & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- ATLX
- Stock Information
- Founded
- CRVO 2001
- ATLX 2011
- Country
- CRVO United States
- ATLX Brazil
- Employees
- CRVO N/A
- ATLX N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- CRVO Health Care
- ATLX Industrials
- Exchange
- CRVO Nasdaq
- ATLX Nasdaq
- Market Cap
- CRVO 98.3M
- ATLX 101.9M
- IPO Year
- CRVO N/A
- ATLX N/A
- Fundamental
- Price
- CRVO $2.11
- ATLX $6.90
- Analyst Decision
- CRVO Buy
- ATLX Strong Buy
- Analyst Count
- CRVO 8
- ATLX 3
- Target Price
- CRVO $38.75
- ATLX $33.17
- AVG Volume (30 Days)
- CRVO 303.4K
- ATLX 85.6K
- Earning Date
- CRVO 11-12-2024
- ATLX 11-08-2024
- Dividend Yield
- CRVO N/A
- ATLX N/A
- EPS Growth
- CRVO N/A
- ATLX N/A
- EPS
- CRVO N/A
- ATLX N/A
- Revenue
- CRVO $10,066,550.00
- ATLX $543,657.00
- Revenue This Year
- CRVO $34.17
- ATLX N/A
- Revenue Next Year
- CRVO N/A
- ATLX $8,777.97
- P/E Ratio
- CRVO N/A
- ATLX N/A
- Revenue Growth
- CRVO 116.29
- ATLX N/A
- 52 Week Low
- CRVO $1.80
- ATLX $6.12
- 52 Week High
- CRVO $26.38
- ATLX $26.24
- Technical
- Relative Strength Index (RSI)
- CRVO 28.68
- ATLX 48.46
- Support Level
- CRVO $2.03
- ATLX $6.80
- Resistance Level
- CRVO $2.17
- ATLX $7.25
- Average True Range (ATR)
- CRVO 0.16
- ATLX 0.45
- MACD
- CRVO 0.30
- ATLX 0.05
- Stochastic Oscillator
- CRVO 23.08
- ATLX 37.23
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. They intend to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.